about
Study of the Effect of Eplerenone on Heart Function in Women Receiving Anthracycline Chemotherapy for Breast CancerSearch of Biomarkers of Mineralocorticoid Receiver Activity : the Value of Neutrophil Gelatinase Associated Lipocalin (NGAL)in Serum or Urine in HumanSTITCH2 (Simplified Therapeutic Intervention to Control Hypertension and Hypercholesterolemia)Double Blind Crossover Comparison of Diuretics in the YoungAldosterone and the Metabolic SyndromeSpironolactone in Adult Congenital Heart DiseaseStudy to Investigate the Natriuretic Effects, Safety, Tolerability and Pharmacokinetics of BAY94-8862Effects of Spironolactone on Collagen Metabolism in Patients With Pulmonary Arterial HypertensionMineralocorticoid Receptor Antagonist and Kidney Allograft HistologyThe Role of Aldosterone on Augmented Exercise Pressor Reflex in HypertensionEplerenone for the Treatment of Central Serous ChorioretinopathyAcetazolamide and Spironolactone to Increase Natriuresis in Congestive Heart FailureThe Effects of Eplerenone on Markers of Myocardial Fibrosis in Adult Congenital Heart DiseaseAldosterone in Diabetic NephropathyImportance of Aldosterone in the Pathogenesis of Hypertensive Heart DiseaseSpironolactone and Prevention of Peritoneal Fibrosis in Peritoneal DialysisRole of Mineralocorticoid Receptor in Diabetic Cardiovascular DiseaseHemodynamic Effects of Spironolactone in Patients With Heart FailureAdjuvant Anti-Mineralocorticoid-Receptor Treatment in Anti-VEGF Refractory Neovascular Age-Related Macular DegenerationStudy in HFpEF Patients to Compare the Effect of AZD9977 and Spironolactone on Serum PotassiumUsing the Drug Spironolactone to Test If It Reduces Protein Leakage From the KidneyRole of Active Deresuscitation After Resuscitation-2Postoperative Cardiovascular Index Change of Primary AldosteronismSpironolactone Versus Spironolactone Plus Furosemide (SVSSF)Spironolactone With Patiromer in the Treatment of Resistant Hypertension in Chronic Kidney DiseaseHyperandrogenemia and Altered Day-night LH Pulse PatternsRenal Denervation in Refractory HypertensionSpironolactone Plus Metformin in Polycystic Ovary SyndromeEffect of Spironolactone in Treating Chronic Non-resolutive Central Serous ChorioretinitisEffect of Spironolactone on Adrenal or Ovarian Androgen Production in Overweight Pubertal Girls With Androgen ExcessBAY94-8862 Dose Finding Trial in Subjects With Chronic Heart Failure and Mild (Part A) or Moderate (Part B) Chronic Kidney DiseaseA Single Dose Study Of Antimineralocorticoid Activity Of PF-03882845 In Healthy VolunteersEvaluation of Cortisol Resistance in Young Sedentary and Endurance-Trained MenSpironolactone Versus Indapamide in Obese and Hypertensive PatientsMineralocorticoid Receptor Antagonism Clinical Evaluation in Atherosclerosis Add-OnSpironolactone & RAAS: Effect on Urinary Proteinuria & Mean Epidermal Growth Factor ReceptorHypoglycemia and Autonomic Nervous System Function-BThe Effect of Spironolactone on Acute Kidney Injury in Patients Undergoing Coronary AngiographyPrevention of the Progression of Coronary Calcification With Use of Spironolactone in Peritoneal Dialysis PatientsHigh-dose Aldosterone Antagonist for Acute Decompensated Heart Failure
P4844
Q61713103-B08017E9-1FF1-4BF3-BAC7-8C0ADAFC561BQ61894462-475E6256-6BCE-4576-A2FB-E35D99D36056Q61915272-FA38D041-E36C-455B-B545-7C1440C238ABQ61921149-308B92E0-3E33-4625-B9A5-0AFDA50ACBD8Q61935815-87DEC354-4118-4FDD-AD38-C4B0FA3F4539Q61938915-5DDA2F94-B7FA-4825-881F-D72943D8A270Q61955379-ABF0F1CA-EF49-45C7-A6E5-979A3E2A5F0FQ61955960-D6364D11-7EAE-49B2-9278-0621EF05C485Q61956134-535E95B6-48E1-4E3C-9AA1-C3775509F461Q61969605-C7A4FA73-7414-4383-BCB7-D9EF5CDFF218Q61970080-F0CEEDDD-7A80-4DC8-A174-54897B0DF30DQ61975128-C8DC5E3A-7C52-4236-B21E-5C4AF5957D1AQ61975271-FF617FD7-0FF4-47A8-BCDF-ED937F05DE2DQ61980646-514556C3-33DA-4ACA-9C5E-9AFCF4BB25B2Q61981068-5896AD9B-70E2-45C3-B33D-34FF7DCDED03Q61981072-170D3286-1452-448F-A8F2-E6D8C7C7FF78Q61981100-85C074B9-C9B3-48FF-93F5-76209B5DCDBFQ61981517-104B301E-F36E-41B3-B9B6-9B60C4A3D73EQ62034556-6DB03F71-6AF4-49EB-8A04-7A71333A753CQ62054809-DDA0A52E-AAA2-4FDC-9BB0-9969F01EE57DQ62105693-570DC802-CD2A-4C07-AB59-22830FB65D4BQ62819806-3E67B1B1-EC21-47BF-ACE0-6AFCD9A792C5Q63062163-53D47D26-27B4-4C9F-815A-46E9031DA7B6Q63062671-70D1CB83-28E9-4346-B5AC-F68DB1F51E59Q63229036-10192D61-0BEF-487D-A8D4-5606ADE30E9CQ63229228-9CF1C804-F164-4AF0-A43F-0E7BE357F1D6Q63316731-5AA15ECF-056F-4453-B215-FEF9AC475A25Q63318542-02907A1F-C56A-4149-A6D4-88F314287AD4Q63319663-C6ED6979-8615-4BE1-8221-31C9966A519AQ63321833-7A5591D4-97A0-46D7-AF11-B6981E29B8B3Q63336291-3D6EA74A-AFC2-42C0-9977-1E483EB8AD14Q63338482-71F1ED38-E153-4D0D-B535-1B4CDE145CB5Q63339405-1BD20473-91F7-48FC-AA12-C52B75CB4D31Q63393672-F45EA802-946F-4DDA-B69A-09470CD7AB7EQ63394432-9BB1E59F-2BC9-4493-8CFF-725C4CB77CB1Q63398757-C4EE5DC2-8CDC-4924-98EA-A7E9333F72BAQ63404393-18B8EF76-842B-467A-B1D6-8146A335A3C1Q63533978-003C4601-85AC-4A05-AA1C-BC712E17674DQ63570952-A4B6B1F8-DDF3-4B5A-9836-9F03BE132546Q63577704-32185D0A-5E74-46E6-9EBC-A36650274F18
P4844
description
article
@en
im Februar 2017 veröffentlichter wissenschaftlicher Artikel
@de
наукова стаття, опублікована в лютому 2017
@uk
ലേഖനം
@ml
name
Spironolactone
@en
type
label
Spironolactone
@en
prefLabel
Spironolactone
@en
P2093
P1476
Spironolactone
@en
P2093
Andrew Wilcock
Laura Carone
Mary Mihalyo
Sarah Charlesworth
Stephen G. Oxberry
P304
P356
10.1016/J.JPAINSYMMAN.2016.12.320
P577
2017-02-01T00:00:00Z